Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| HAEMONETICS CORP | 39,414 | reported | 15 Sept 2015 | tx 303+1,584,763−723,964 |
| CONMED Corp | 0 | reported | 03 Jun 2025 | tx 74+90,337−49,780 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Jun 2025 | EXERCISE | CONMED Corp | 479 | 0.00 USD | |
| 02 Jun 2025 | GRANT_AWARD | CONMED Corp | 8,061 | 0.00 USD | deriv |
| 03 Jun 2025 | EXERCISE | CONMED Corp | 479 | 0.00 USD | deriv |
| 02 Jun 2025 | GRANT_AWARD | CONMED Corp | 668 | 0.00 USD | deriv |
| 31 May 2024 | EXERCISE | CONMED Corp | 302 | 0.00 USD | |
| 31 May 2024 | EXERCISE | CONMED Corp | 302 | 0.00 USD | deriv |
| 03 Jun 2024 | GRANT_AWARD | CONMED Corp | 479 | 0.00 USD | deriv |
| 03 Jun 2024 | GRANT_AWARD | CONMED Corp | 5,503 | 0.00 USD | deriv |
| 07 Jun 2023 | SALE | CONMED Corp | 812 | 129.01 USD | |
| 01 Jun 2023 | EXERCISE | CONMED Corp | 335 | 0.00 USD | |
| 01 Jun 2023 | EXERCISE | CONMED Corp | 335 | 0.00 USD | deriv |
| 01 Jun 2023 | GRANT_AWARD | CONMED Corp | 302 | 0.00 USD | deriv |
| 01 Jun 2023 | GRANT_AWARD | CONMED Corp | 2,826 | 0.00 USD | deriv |
| 01 May 2023 | SALE | CONMED Corp | 2,072 | 125.00 USD | |
| 01 Jun 2022 | EXERCISE | CONMED Corp | 812 | 0.00 USD | |
| 01 Jun 2022 | GRANT_AWARD | CONMED Corp | 3,453 | 0.00 USD | deriv |
| 01 Jun 2022 | GRANT_AWARD | CONMED Corp | 335 | 0.00 USD | deriv |
| 01 Jun 2022 | EXERCISE | CONMED Corp | 812 | 0.00 USD | deriv |
| 02 Feb 2022 | TAX_WITHHOLDING | CONMED Corp | 241 | 139.03 USD | |
| 02 Feb 2022 | SALE | CONMED Corp | 1,843 | 135.06 USD | |
| 02 Feb 2022 | EXERCISE | CONMED Corp | 1,843 | 73.94 USD | |
| 02 Feb 2022 | EXERCISE | CONMED Corp | 1,000 | 33.43 USD | |
| 02 Feb 2022 | EXERCISE | CONMED Corp | 1,000 | 39.64 USD | |
| 02 Feb 2022 | TAX_WITHHOLDING | CONMED Corp | 286 | 139.03 USD | |
| 02 Feb 2022 | EXERCISE | CONMED Corp | 1,000 | 55.70 USD |
2 purchases reported after at least 12 months of silence — most recent on 01 May 2008.